APPLIED DNA SCIENCES INC's ticker is APDN and the CUSIP is 03815U201. A total of 37 filers reported holding APPLIED DNA SCIENCES INC in Q3 2016. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $6,000 | – | 1,834 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Benchmark Capital Advisors | 180,000 | $549,000 | 0.41% |
| CHASE INVESTMENT COUNSEL CORP | 77,563 | $236,000 | 0.10% |
| Crosspoint Capital Strategies, LLC | 19,321 | $59,000 | 0.08% |
| DUMONT & BLAKE INVESTMENT ADVISORS LLC | 20,921 | $64,000 | 0.03% |
| REILLY FINANCIAL ADVISORS, LLC | 50,000 | $153,000 | 0.03% |
| Onex Canada Asset Management Inc. | 20,000 | $60,000 | 0.01% |
| WILLIAMS JONES & ASSOCIATES LLC | 48,050 | $147,000 | 0.00% |
| D. SCOTT NEAL, INC. | 384 | $1,000 | 0.00% |
| OPPENHEIMER & CO INC | 13,527 | $41,000 | 0.00% |
| Creative Planning | 56,234 | $172,000 | 0.00% |